Tylobeck® Injectable Solution is a macrolide antibiotic containing Tylosin 200 mg/ml, developed by Klybeck Life Science for use in large animals, including cattle, sheep, and goats. Tylosin is well known for its high efficacy against Gram-positive bacteria and Mycoplasma species, particularly in respiratory, gastrointestinal, and systemic infections.

Tylobeck® is indicated for the treatment of tylosin-susceptible bacterial infections, supporting rapid clinical response and recovery. The injectable formulation ensures reliable systemic distribution, making it suitable for use in herd health management under veterinary supervision.

The product is supplied in a 100 ml vial and is intended strictly for veterinary use.